<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
		<id>https://www.wiki-willebadessen.de/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=NewtonMebane2</id>
		<title>wiki-willebadessen.de - Benutzerbeiträge [de]</title>
		<link rel="self" type="application/atom+xml" href="https://www.wiki-willebadessen.de/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=NewtonMebane2"/>
		<link rel="alternate" type="text/html" href="https://www.wiki-willebadessen.de/index.php?title=Spezial:Beitr%C3%A4ge/NewtonMebane2"/>
		<updated>2026-06-21T13:30:02Z</updated>
		<subtitle>Benutzerbeiträge</subtitle>
		<generator>MediaWiki 1.25.1</generator>

	<entry>
		<id>https://www.wiki-willebadessen.de/index.php?title=Neurotoxicity_Of_Synthetic_Cannabinoids_JWH-081_And_JWH-210&amp;diff=20779</id>
		<title>Neurotoxicity Of Synthetic Cannabinoids JWH-081 And JWH-210</title>
		<link rel="alternate" type="text/html" href="https://www.wiki-willebadessen.de/index.php?title=Neurotoxicity_Of_Synthetic_Cannabinoids_JWH-081_And_JWH-210&amp;diff=20779"/>
				<updated>2026-05-23T07:37:41Z</updated>
		
		<summary type="html">&lt;p&gt;NewtonMebane2: Die Seite wurde neu angelegt: „The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by huma…“&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicating oxidative defluorination (loss of fluorine with addition of hydroxy [https://cannabinoidsrc4f-adb.com/ special info] group&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;This might be due to the low activity of numerous metabolizing enzymes resulting in lower drug biotransformation . HepG2 model detected the major ester hydrolysis metabolite of 4F-MDMB-BINACA in abundance but the rest of the metabolites were found in a small amount. Elegans and HLM models detected all of the in-vivo metabolites (100%), whilst HepG2 cells detected 7 out of the 8 in-vivo metabolites (87.5%). Hence, structural elucidation could not be confirmed unless a reference standard is made availabl&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fig. 2. &amp;lt;br&amp;gt;Separation of compounds was performed on a 2.1 mm×100 mm, 1.7 special info μm particle size ACQUITY Torus™ DIOL analytical column (Waters) with guard cartridge. Measurements were performed by an ACQUITY UPC2 supercritical fluid chromatography system (Waters) coupled with a Xevo TQ-S Triple Quadrupole Mass Spectrometer (Waters). During the death scene examination, multiple cigarette butts without filters were found in an ashtray; also found were alcohol bottles, an unopened box of nebivolol-containing drug, and 18 g of unrecognizable herbal residue in a cigarette box.&amp;lt;br&amp;gt;Victim B also brought &amp;quot;something resembling a drug&amp;quot; (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2, in vitro half-life (t1/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Figure 1. &amp;lt;br&amp;gt;Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act 2016. The corresponding indole core analogue, 4F-MDMB-BICA (4F-MDMB-BUTICA), has also been widely sold as a designer drug by chemical providers on the internet, first being identified in May 2020. It has been used as an active ingredient in synthetic cannabis products and sold as a designer drug since late 2018. 4F-MDMB-BINACA (also known as MDMB-4F-BINACA using systematic EMCDDA nomenclature or 4F-MDMB-BUTINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family.&amp;lt;br&amp;gt;Fig.&lt;/div&gt;</summary>
		<author><name>NewtonMebane2</name></author>	</entry>

	<entry>
		<id>https://www.wiki-willebadessen.de/index.php?title=Benutzer:NewtonMebane2&amp;diff=20778</id>
		<title>Benutzer:NewtonMebane2</title>
		<link rel="alternate" type="text/html" href="https://www.wiki-willebadessen.de/index.php?title=Benutzer:NewtonMebane2&amp;diff=20778"/>
				<updated>2026-05-23T07:36:50Z</updated>
		
		<summary type="html">&lt;p&gt;NewtonMebane2: Die Seite wurde neu angelegt: „30 year-old VP Accounting Ira Siney, hailing from Listowel enjoys watching movies like Eve of Destruction and Stand-up comedy. Took a trip to Historic Town of…“&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;30 year-old VP Accounting Ira Siney, hailing from Listowel enjoys watching movies like Eve of Destruction and Stand-up comedy. Took a trip to Historic Town of Goslar and drives a Safari.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;My blog post; [https://cannabinoidsrc4f-adb.com/ Check Out cannabinoidsrc4f-adb.com]&lt;/div&gt;</summary>
		<author><name>NewtonMebane2</name></author>	</entry>

	</feed>